Clinical trial Recruiting at 6 sites Observational Ages 18 and up

TachoSil vs DuraSeal for Supporting Dural Sealing in Adults

Official title: Effectiveness and Safety of TachoSil® Fibrin Sealant Patch in Comparison to a Hydrogel Sealant for Supporting Dural Sealing Among Adult Inpatients in the United States: A Retrospective, Non-Inferiority, Cohort Study

Run by Corza Medical GmbH · NCT07927413 · Data updated 2026-11-12

This retrospective study looks at whether TachoSil works as well as DuraSeal to prevent CSF leaks or pseudomeningoceles after cranial or spinal surgeries in adults.

More CerebroSpinal Fluid (CSF) Leak trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment600 (estimated)
SponsorCorza Medical GmbH
Industry-sponsored
Drugs / interventionsradiation
Locations6 sites (Baltimore, Maryland and 5 other locations)
StatusRecruiting
StartedFebruary 13, 2026
Main results expectedNovember 16, 2026
Study endsNovember 16, 2026
Registry record updatedNovember 10, 2026
Trial IDNCT07927413 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) who had inpatient cranial or spinal surgery with dural sealing and used either TachoSil or DuraSeal at participating sites between 2017 and 2026.

Probably not a fit

Patients whose surgery did not involve dural sealing with these sealants or who do not experience CSF leaks or pseudomeningoceles may not see a benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study analyzes medical records from adults who had cranial or spinal surgery with dural sealing, comparing outcomes between TachoSil and DuraSeal sealants. It uses 1:1 propensity score matching to see if TachoSil is non-inferior to DuraSeal and to evaluate safety and effectiveness through 90-day post-surgery events. Primary outcomes include clinically evident CSF leak or pseudomeningocele within 90 days, with additional safety considerations being monitored. Data are drawn from multiple US institutions and led by Corza Medical GmbH, with CIAS, Premier, Inc. Applied Sciences as collaborators.

Why it matters

Potential benefit: If successful, the findings could inform surgeons' choice of dural sealants to reduce CSF-related complications and improve patient safety.

How similar studies have gone: Prior work in dural sealant comparisons has shown varying effectiveness; this study adds real-world evidence using propensity score matching.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged ≥ 18 years
* Had an inpatient encounter to select sites with a cranial or spinal neurological surgery that involves dural sealing performed and discharged during January 1, 2017, and March 31, 2026
* Had use of TachoSil® or DuraSeal® sealants during the cranial or spinal neurological surgery as supportive dural sealing method

Note: Any surgery meeting the above criteria is considered index surgery

Exclusion Criteria:

* Index surgery was trauma-related
* Had an infection within 7 days prior to index date
* Had any neurosurgery involving dural opening during the 12-month look-back period
* Had neoplasm of dura mater/meningioma, requiring resection of dura during index visit (the earliest visit meeting selection criteria) or 12-month look-back period
* Was pregnant at index visit
* Had a CSF leak during the 12-month look-back period
* If the surgical approach was transbasal or transpetrosal, if the arachnoid membrane and CSF- containing system remained intact, or if there was \>1 dura opening (excluding extra ventricular or lumbar drains) during index surgery
* Had use of Evarrest patch, Tisseel, Adherus, CraniSeal, Duragen, fibrin glue or other dural sealing products during index surgery
* Had radiation therapy to surgical field in the 3 months prior to index date
* Had chronic corticosteroid use in the 3 months prior to index date
* Had both TachoSil® and DuraSeal® used for dural closure during index neurological surgery

Where it's running

  • Johns Hopkins University
    Baltimore, Maryland, United States
    Recruiting
  • Columbia University
    New York, New York, United States
    Recruiting
  • University of Cincinnati College of Medicine
    Cincinnati, Ohio, United States
    Recruiting
  • Thomas Jefferson University
    Philadelphia, Pennsylvania, United States
    Recruiting
  • Alleghany Health Network
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Swedish Health Services
    Seattle, Washington, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.